AB 1460 (Rogers, D-Santa Rosa) Details
July 16 hearing in the Senate Health Committee postponed by the committee. Two-year bill.
AB 1460 would prohibit drug manufacturers from engaging in discriminatory practices that prevent or interfere with a qualifying nonhospital 340B community clinic’s ability to purchase or deliver 340B discounted drugs through contract pharmacies. This bill would also allow prescription drug manufacturers to request deidentified claims data from 340B-covered entities once a year to investigate duplicate discounts...
This content is restricted to members.
Mark Farouk
Adam Dorsey